Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with MYC and MYC/BCL2 rearrangements, especially in germinal center cell-type tumors.

LIM-domain only 2 (LMO2) is a highly conserved cysteine-rich protein that is a critical regulator of hematopoietic cell development, stem cell maintenance, and is implicated in angiogenesis [1,2]. ...